XBiotech Inc

XBIT

Get informed when a big investor buys or sells

Market Cap$66.77M

Close$

Compare to Similar Companies

	P/E Ratio	Dividends	Return on Equity	Price-to-Sales	Debt-to-Equity
XBiotech Inc	-1.5	-	-35%	-	-

$4.12

Current Fair Value

91.5% upside

Undervalued by 91.5% based on the discounted cash flow analysis.

Share Statistics

Market cap	$66.77 Million
Enterprise Value	$-40,927,869.00
Dividend Yield	$- (-)
Earnings per Share	$-1.49
Beta	0.85
Outstanding Shares	30,487,731

Return

Return on Equity	-35.13%
Return on Assets	-33.77%
Return on Invested Capital	-35.81%

Valuation & Multiples

P/E Ratio	-1.48
PEG	-0.52
Price to Sales	-
Price to Book Ratio	0.54
Enterprise Value to Revenue	-
Enterprise Value to EBIT	0.88
Enterprise Value to Net Income	0
Total Debt to Enterprise	-0.04
Debt to Equity	0.01

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date

August 13, 2026

EPS Estimate

$0.03

Average shareholder expectation

Revenue Estimate

$7.00 M

Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio	0.4207▲ 42.06%
Total Calls	104,600▲ 395.73%
Total Puts	44,000▲ Infinity%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %	6.50%▼ 0.04%
Total Invested	$4.56M▼ 2.66%
Investors Holding	39▲ 1.00%

ESG Score